Frequency of BCL2 and BCL6 translocations in follicular lymphoma: Relation with histological and clinical features

Leukemia and Lymphoma

Volumn 49, Issue 1, 2008, Pages 95-101

  Díaz Alderete, Andrea ^a   Doval, Angela ^a   Camacho, Francisca ^a   Verde, Lydia ^a   Sabin, Pilar ^a   Arranz Sáez, Reyes ^a   Bellas, Carmen ^a   Corbacho, Carlos ^a   Gil, Guana ^a   Perez Martín, María ^a   Ruiz Marcellán, Maria ^a   Gonzalez, Leocricia ^a   Montalbán, Carlos ^a   Piris, Miguel ^a   Menarguez, Javier ^a  

^a HOSPITAL GENERAL UNIVERSITARIO GREGORIO MARAÑÓN   (Spain)

Author keywords

Cytogenetics; Lymphoma and Hodgkin disease; Morphology

Indexed keywords

LACTATE DEHYDROGENASE; PROTEIN BCL 2; PROTEIN BCL 6;

ADULT; ARTICLE; CANCER CLASSIFICATION; CANCER GRADING; CHROMOSOME REARRANGEMENT; CHROMOSOME TRANSLOCATION; CLINICAL FEATURE; CONTROLLED STUDY; DATA ANALYSIS; FEMALE; FOLLICULAR LYMPHOMA; HISTOPATHOLOGY; HUMAN; MAJOR CLINICAL STUDY; MALE; PATIENT CODING; PRIORITY JOURNAL;

ADULT; AGED; BONE MARROW; CYTOGENETIC ANALYSIS; GENE FREQUENCY; GENES, BCL-2; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; LYMPHOMA, FOLLICULAR; MIDDLE AGED; PROTO-ONCOGENE PROTEINS C-BCL-6; SURVIVAL ANALYSIS; TRANSLOCATION, GENETIC;

EID: 38549123879     PISSN: 10428194     EISSN: 10292403     Source Type: Journal    
DOI: 10.1080/10428190701742472     Document Type: Article

References (28)

1. Armitage, J. O. and Weisenburger, D. D. (1998) New approach to classifying non-Hodgkin's lymphomas: Clinical features of the major histologic subtypes. Non-Hodgkin's Lymphoma Classification Project. J Clin Oncol, 16, pp. 2780-2795.
2. Biagi, J. J. and Seymour, J. F. (2002) Insights into the molecular pathogenesis of follicular lymphoma arising from analysis of geographic variation. Blood, 99, pp. 4265-4275.
3. Dave, S. S., Wright, G., Tan, B., Rosenwald, A., Gascoyne, R. D. and Chan, W. C. (2004) Prediction of survival in follicular lymphoma based on molecular features of tumor-infiltrating immune cells. N Engl J Med, 351, pp. 2159-2169.
4. Roulland, S., Navarro, J. M., Grenot, P., Milili, M., Agopian, J. and Montpellier, B. (2006) Follicular lymphoma-like B cells in healthy individuals: A novel intermediate step in early lymphomagenesis. J Exp Med, 203, pp. 2425-2431.
5. Marsden, V. S. and Strasser, A. (2003) Control of apoptosis in the immune system: Bcl-2, BH3-only proteins and more. Annu Rev Immunol, 21, pp. 71-105.
6. de Jong, D. (2005) Molecular pathogenesis of follicular lymphoma: A cross talk of genetic and immunologic factors. J Clin Oncol, 23, pp. 6358-6363.
7. Meijerink, J. P. (1997) t(14;18), a journey to eternity. Leukemia, 11, pp. 2175-2187.
8. Luminari, S. and Federico, M. (2006) Prognosis of follicular lymphomas. Hematol Oncol, 24, pp. 64-72.
9. (2001) Pathology and Genetic of Tumours of Haematopoietic and Lymphoid Tissues, pp. 162-167. IARC Press, Lyons, France
10. Shaffer, A. L., Yu, X., He, Y., Boldrick, J., Chan, E. P. and Staudt, L. M. (2000) BCL-6 represses genes that function in lymphocyte differentiation, inflammation, and cell cycle control. Immunity, 13, pp. 199-212.
11. Solal-Celigny, P., Roy, P., Colombat, P., White, J., Armitage, J. O. and Arranz-Saez, R. (2004) Follicular lymphoma international prognostic index. Blood, 104, pp. 1258-1265.
12. Buske, C., Hoster, E., Dreyling, M., Hasford, J., Unterhalt, M. and Hiddemann, W. (2006) The Follicular Lymphoma International Prognostic Index (FLIPI) separates high-risk from intermediate- or low-risk patients with advanced-stage follicular lymphoma treated front-line with rituximab and the combination of cyclophosphamide, doxorubicin, vincristine, and prednisone (R-CHOP) with respect to treatment outcome. Blood, 108, pp. 1504-1508.
13. Arcaini, L., Colombo, N., Passamonti, F., Burcheri, S., Orlandi, E. and Brusamolino, E. (2006) Correlation of the FLIPI score for follicular lymphoma with period of diagnosis and type of treatment. Leuk Res, 30, pp. 277-282.
14. Plancarte, F., Lopez-Guillermo, A., Arenillas, L., Montoto, S., Gine, E. and Muntanola, A. (2006) Follicular lymphoma in early stages: High risk of relapse and usefulness of the Follicular Lymphoma International Prognostic Index to predict the outcome of patients. Eur J Haematol, 76, pp. 58-63.
15. Montoto, S., Lopez-Guillermo, A., Ferrer, A., Camos, M., Alvarez-Larran, A. and Bosch, F. (2002) Survival after progression in patients with follicular lymphoma: Analysis of prognostic factors. Ann Oncol, 13, pp. 523-530.
16. Montoto, S., Lopez-Guillermo, A., Colomer, D., Esteve, J., Bosch, F. and Ferrer, A. (2003) Incidence and clinical significance of bcl-2/IgH rearrangements in follicular lymphoma. Leuk Lymphoma, 44, pp. 71-76.
17. Alvaro, T., Lejeune, M., Camacho, F. I., Salvado, M. T., Sanchez, L. and Garcia, J. F. (2006) The presence of STAT1-positive tumor-associated macrophages and their relation to outcome in patients with follicular lymphoma. Haematologica, 91, pp. 1605-1612.
18. A predictive model for aggressive non-Hodgkin's lymphoma (1993) The International Non-Hodgkin's Lymphoma Prognostic Factors Project. N Engl J Med, 329, pp. 987-994.
19. Garcia, J. F., Maestre, L., Lucas, E., Sanchez-Verde, L., Romero-Chala, S. and Piris, M. A. (2006) Genetic immunization: A new monoclonal antibody for the detection of BCL-6 protein in paraffin sections. J Histochem Cytochem, 54, pp. 31-38.
20. Buno, I., Nava, P., Alvarez-Doval, A., Alvarez-Rodriguez, F., Diez-Martin, J. L. and Menarguez, J. (2005) Lymphoma associated chromosomal abnormalities can easily be detected by FISH on tissue imprints. An underused diagnostic alternative. J Clin Pathol, 58, pp. 629-633.
21. Lopez-Guillermo, A., Cabanillas, F., McDonnell, T. I., McLaughlin, P., Smith, T. and Pugh, W. (1999) Correlation of bcl-2 rearrangement with clinical characteristics and outcome in indolent follicular lymphoma. Blood, 93, pp. 3081-3087.
22. Jardin, F., Gaulard, P., Buchonnet, G., Contentin, N., Lepretre, S. and Lenain, P. (2002) Follicular lymphoma without t(14;18) and with BCL-6 rearrangement: A lymphoma subtype with distinct pathological, molecular and clinical characteristics. Leukemia, 16, pp. 2309-2317.
23. Ott, G., Katzenberger, T., Lohr, A., Kindelberger, S., Rudiger, T. and Wilhelm, M. (2002) Cytomorphologic, immunohistochemical, and cytogenetic profiles of follicular lymphoma: 2 types of follicular lymphoma grade 3. Blood, 99, pp. 3806-3812.
24. Bosga-Bouwer, A. G., Berg, A van den, Haralambieva, E., de Jong, D., Boonstra, R. and Kluin, P. (2006) Molecular, cytogenetic, and immunophenotypic characterization of follicular lymphoma grade 3B: A separate entity or part of the spectrum of diffuse large B-cell lymphoma or follicular lymphoma?. Hum Pathol, 37, pp. 528-533.
25. Karube, K., Guo, Y., Suzumiya, J., Sugita, Y., Nomura, Y. and Yamamoto, K. (2007) CD10(-)MUM1(+) follicular lymphoma lacks BCL2 translocation and shows characteristic biological and clinical features. Blood, 109, pp. 3076-3079.
26. Sekiguchi, N., Kobayashi, Y., Yokota, Y., Kusumoto, S., Tanimoto, K. and Watanabe, T. (2005) Follicular lymphoma subgrouping by fluorescence in situ hybridization analysis. Cancer Sci, 96, pp. 77-82.
27. Cattoretti, G., Pasqualucci, L., Ballon, G., Tam, W., Nandula, S. V. and Shen, Q. (2005) Deregulated BCL6 expression recapitulates the pathogenesis of human diffuse large B cell lymphomas in mice. Cancer Cell, 7, pp. 445-455.
28. Yang, X., Lee, K., Said, J., Gong, X. and Zhang, K. (2006) Association of Ig/BCL6 translocations with germinal center B lymphocytes in human lymphoid tissues: Implications for malignant transformation. Blood, 108, pp. 2006-2012.